Literature DB >> 1115366

Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.

R P Fogdall, R D Miller.   

Abstract

The neuromuscular effects of d-tubocurarine (dTc), pacuronium, and succinylcholien (SCh) were studied in 37 unpremedicated adult surgical patients anesthetized with 1.25 MAC enflurance in oxygen. The relaxant doses that produced 50 per cent depression of twitch height (ED50) were 1.57, 0.29, and 4.9 mg/m2 for dTc, pancuronium, and SCh, respectively. These doses are approximately 3.1, 1.7, and 1.0 times less than the amount of dTc, pancuronium, and SCh required to produce 50 per cent depression of twitch height during halothane anesthesia but are the same as ED50 values during isoflurane anesthesia. In eight additional unpremedicated patients anesthesia was maintained at 0.71 MAC enflurane in oxygen (five patients) or 1.67 MAC enflurane in oxygen (three patients). Twitch depression following dTc, 1.5 mg/m2, was related directly to alveolar enflurane concentration. Ability to sustain tetanus decreased progressively with increasing tetanic frequencies and decreased with increasing alveolar enflurane concentrations. The authors concluded that smaller doses of dTc and pancuronium are needed for adequate relaxation during enflurane anesthesia than during equi-MAC halothane anesthesia, and that higher alveolar enflurane concentrations reduce the dose of dTc necessary to produce a given amount of paralysis. Also, neuromuscular effects of enflurane in combination with dTc or pancuronium are not significantly different from those seen suring equi-MAC isoflurane anesthesia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115366     DOI: 10.1097/00000542-197502000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

2.  Clinical pharmacokinetics of muscle relaxants.

Authors:  L B Wingard; D R Cook
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

3.  Nitrous oxide potentiates vecuronium neuromuscular blockade in humans.

Authors:  P Fiset; P Balendran; D R Bevan; F Donati
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

4.  Effect of enflurane and fentanyl on the clinical characteristics of long-term succinylcholine infusion.

Authors:  F Donati; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1982-01

5.  Neuromuscular effects of sevoflurane in patients with myasthenia gravis.

Authors:  T Morita; H Tsukagoshi; D Kurosaki; T Sugaya; D Yoshikawa; H Shimada
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

6.  Sevoflurane enhances neuromuscular blockade by increasing the sensitivity of skeletal muscle to neuromuscular blockers.

Authors:  Ling Ye; Yunxia Zuo; Peng Zhang; Pingliang Yang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.